Document is current
Any future updates will be listed below
-
Authors
Arnold, Paige K. https://orcid.org/0000-0002-0851-2057
Jackson, Benjamin T. https://orcid.org/0000-0003-1089-4362
Paras, Katrina I. https://orcid.org/0000-0001-9743-5710
Brunner, Julia S. https://orcid.org/0000-0002-3195-147X
Hart, Madeleine L. https://orcid.org/0000-0001-9125-0627
Newsom, Oliver J.
Alibeckoff, Sydney P.
Endress, Jennifer https://orcid.org/0000-0002-7538-6302
Drill, Esther https://orcid.org/0000-0002-3315-4538
Sullivan, Lucas B. https://orcid.org/0000-0002-6745-8222
Finley, Lydia W. S. https://orcid.org/0000-0003-4023-7574
- License Information
-
More Information
Article History
Received: 19 February 2021
Accepted: 26 January 2022
First Online: 9 March 2022
Competing interests
: P.K.A., B.T.J. and L.W.S.F. are listed as inventors on a provisional patent application (US provisional application no. 63/272,940) filed by the Memorial Sloan Kettering Cancer Center. The patent application covers the use of ACL inhibitors to modify the self-renewal potential of ES cells. The other authors declare no competing interests.
